| Market Capitalization (Millions $) |
2 |
| Shares
Outstanding (Millions) |
2 |
| Employees |
12 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-20 |
| Cash Flow (TTM) (Millions $) |
19 |
| Capital Exp. (TTM) (Millions $) |
0 |
Allarity Therapeutics Inc
Allarity Therapeutics Inc. is a biotechnology company headquartered in Denmark. The company focuses on developing personalized medicine and innovative drug discovery solutions for the treatment of cancer. Their proprietary drug response predictor (DRP) technology helps identify which patients are likely to respond positively to certain drug treatments, based on molecular profiling and analysis.
Allarity Therapeutics aims to optimize the use of existing drugs and accelerate the development of new therapies by identifying and targeting specific patient populations that will benefit the most. Their DRP technology evaluates the unique genetic profile of each patient to tailor treatments and improve clinical outcomes. This personalized approach has the potential to significantly improve patient care and reduce healthcare costs by avoiding ineffective treatments.
The company's pipeline includes several drug candidates in various stages of development for targeted cancer treatments. Allarity Therapeutics collaborates with research institutions, academic partners, and pharmaceutical companies to advance their drug development programs. Their goal is to bring effective therapies to the market and improve the lives of cancer patients worldwide.
Company Address: 24 School Street, 2nd Floor Boston 2108 MA
Company Phone Number: 426-4664 Stock Exchange / Ticker: NASDAQ ALLR
|
